Login / Signup

Access to gene therapy for rare diseases when commercialization is not fit for purpose.

Thomas Andrew FoxJuan Antonio BuerenFabio CandottiAlain FischerAlessandro AiutiArjan Lankesternull nullClaire Booth
Published in: Nature medicine (2023)
Keyphrases
  • gene therapy